Have a personal or library account? Click to login
Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson’s Disease Cover

Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson’s Disease

Tremor and Other Hyperkinetic Movements
Volume 13 (2023): Issue 1
By: Salima Brillman,  Pravin Khemani,  Stuart H. Isaacson,  Rajesh Pahwa,  Ruta Deshpande,  Vivien Zraick,  Apoorva Rajagopal,  Dhira Khosla and  Kathryn H. Rosenbluth  
Open Access
|Aug 2023

References

  1. 1Heusinkveld LE, Hacker ML, Turchan M, Davis TL, Charles D. Impact of Tremor on Patients With Early Stage Parkinson’s Disease. Frontiers in Neurology. 2018; 9: 628. DOI: 10.3389/fneur.2018.00628
    Back to article
  2. 2Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, et al. Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study. Brain. 2018 Mar 1; 141(3): 811–21. DOI: 10.1093/brain/awx376
    Back to article
  3. 3Gigante AF, Bruno G, Iliceto G, Guido M, Liuzzi D, Mancino PV, et al. Action tremor in Parkinson’s disease: frequency and relationship to motor and non-motor signs. Eur J Neurol. 2015 Feb; 22(2): 223–8. DOI: 10.1111/ene.12583
    Back to article
  4. 4Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Arch Neurol. 2001 Oct; 58(10): 1630–4. DOI: 10.1001/archneur.58.10.1630
    Back to article
  5. 5Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society: IPMDS Task Force on Tremor Consensus Statement. Mov Disord. 2018 Jan; 33(1): 75–87. DOI: 10.1002/mds.27121
    Back to article
  6. 6Pietzsch JB, Garner AM, Marks WJ, Jr. Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States. Neuromodulation: Technology at the Neural Interface. 2016; 19(7): 689–97. DOI: 10.1111/ner.12474
    Back to article
  7. 7Pollak P. Chapter 9 – Deep brain stimulation for Parkinson’s disease – patient selection. In: Lozano AM, Hallett M (eds.), Handbook of Clinical Neurology, (pp. 97–105). Elsevier; 2013. (Brain Stimulation; vol. 116). DOI: 10.1016/B978-0-444-53497-2.00009-7
    Back to article
  8. 8Lin PT, Ross EK, Chidester P, Rosenbluth KH, Hamner SR, Wong SH, et al. Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial. Mov Disord. 2018; 33(7): 1182–3. DOI: 10.1002/mds.27350
    Back to article
  9. 9Pahwa R, Dhall R, Ostrem J, Gwinn R, Lyons K, Ro S, et al. An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor. Neuromodulation. 2019 Jul; 22(5): 537–45. DOI: 10.1111/ner.12930
    Back to article
  10. 10Barath AS, Rusheen AE, Min HK, Lee J, Ross E, Shin S, et al. Brain Metabolic Changes with Longitudinal Transcutaneous Afferent Patterned Stimulation in Essential Tremor Subjects. Tremor Other Hyperkinet Mov (N Y). 2020 Dec 16; 10: 52. DOI: 10.5334/tohm.565
    Back to article
  11. 11Isaacson SH, Peckham E, Tse W, Waln O, Way C, Petrossian MT, et al. Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor. Tremor Other Hyperkinet Mov (N Y). 2020; 10(29). DOI: 10.5334/tohm.59
    Back to article
  12. 12Hanajima R, Dostrovsky JO, Lozano AM, Hutchison WD, Davis KD, Chen R, et al. Somatosensory evoked potentials (SEPs) recorded from deep brain stimulation (DBS) electrodes in the thalamus and subthalamic nucleus (STN). Clin Neurophys. 2004 Feb 1; 115(2): 424–34. DOI: 10.1016/j.clinph.2003.09.027
    Back to article
  13. 13Klostermann F, Wahl M, Schomann J, Kupsch A, Curio G, Marzinzik F. Thalamo-cortical processing of near-threshold somatosensory stimuli in humans. Eur J Neurosci. 2009; 30(9): 1815–22. DOI: 10.1111/j.1460-9568.2009.06970.x
    Back to article
  14. 14Hernandez-Martin E, Arguelles E, Deshpande R, Sanger TD. Evoked Potentials During Peripheral Stimulation Confirm Electrode Location in Thalamic Subnuclei in Children With Secondary Dystonia. J Child Neurol. 2020 Oct; 35(12): 799–807. DOI: 10.1177/0883073820931970
    Back to article
  15. 15Koller WC, Pahwa PR, Lyons KE, Wilkinson SB. Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. Neurology. 2000; 55(12 Suppl 6): S29–33.
    Back to article
  16. 16Deiber MP, Pollak P, Passingham R, Landais P, Gervason C, Cinotti L, et al. Thalamic stimulation and suppression of parkinsonian tremor: Evidence of a cerebellar deactivation using positron emission tomography. Brain. 1993; 116(1): 267–79. DOI: 10.1093/brain/116.1.267
    Back to article
  17. 17Koller WC, Herbster G. Adjuvant therapy of parkinsonian tremor. Arch Neurol. 1987 Sep; 44(9): 921–3. DOI: 10.1001/archneur.1987.00520210023013
    Back to article
  18. 18Brillman S, Colletta K, Borucki S, Lin PT, Waln O, Petrossian M, et al. Real-World Evidence of Transcutaneous Afferent Patterned Stimulation for Essential Tremor. Tremor and Other Hyperkinetic Movements. 2022 Sep 1; 12(1): 27. DOI: 10.5334/tohm.715
    Back to article
  19. 19Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1): 41–7. DOI: 10.1002/mds.21198
    Back to article
  20. 20Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM. Potential reliability and validity of a modified version of the Unified Parkinson’s Disease Rating Scale that could be administered remotely. Parkinsonism & Related Disorders. 2013 Feb; 19(2): 218–21. DOI: 10.1016/j.parkreldis.2012.10.008
    Back to article
  21. 21Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M, et al. Assessing tremor severity. Journal of Neurology, Neurosurgery & Psychiatry. 1993 Aug 1; 56(8): 868–73. DOI: 10.1136/jnnp.56.8.868
    Back to article
  22. 22Busner J, Targum SD. The Clinical Global Impressions Scale. Psychiatry (Edgmont). 2007 Jul; 4(7): 28–37.
    Back to article
  23. 23Guy W, National Institute of Mental Health (U.S.). Psychopharmacology Research Branch. Division of Extramural Research Programs. ECDEU assessment manual for psychopharmacology [Internet]. Rockville, Md.: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976 [cited 2021 May 25]. 616 p. Available from: http://archive.org/details/ecdeuassessmentm1933guyw.
    Back to article
  24. 24Giuffrida JP, Riley DE, Maddux BN, Heldman DA. Clinically deployable Kinesia technology for automated tremor assessment. Mov Disord. 2009 Apr 15; 24(5): 723–30. DOI: 10.1002/mds.22445
    Back to article
  25. 25Kassavetis P, Saifee TA, Roussos G, Drougkas L, Kojovic M, Rothwell JC, et al. Developing a Tool for Remote Digital Assessment of Parkinson’s Disease. Mov Disord Clin Pract. 2016 Feb; 3(1): 59–64. DOI: 10.1002/mdc3.12239
    Back to article
  26. 26Belvisi D, Conte A, Cutrona C, Costanzo M, Ferrazzano G, Fabbrini G, et al. Re-emergent tremor in Parkinson’s disease: the effect of dopaminergic treatment. Eur J Neurol. 2018 Jun; 25(6): 799–804. DOI: 10.1111/ene.13619
    Back to article
  27. 27Yu JY, Rajagopal A, Syrkin-Nikolau J, Shin S, Rosenbluth KH, Khosla D, et al. Transcutaneous Afferent Patterned Stimulation Therapy Reduces Hand Tremor for One Hour in Essential Tremor Patients. Front Neurosci. 2020 Nov 12; 14: 530300. DOI: 10.3389/fnins.2020.530300
    Back to article
  28. 28Elble R. The Essential Tremor Rating Assessment Scale. Journal of Neurology & Neuromedicine. 2016; 1(4): 34–8. DOI: 10.29245/2572.942X/2016/4.1038
    Back to article
  29. 29Gandhi KR, Saadabadi A. Levodopa (L-Dopa) [Internet]. StatPearls [Internet]. StatPearls Publishing; 2020 [cited 2021 May 18]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482140/.
    Back to article
  30. 30Deep Brain Stimulation – Advantages, Risks and Conditions Treated [Internet]. [cited 2021 May 18]. Available from: https://www.aans.org/.
    Back to article
  31. 31Goetz CG, Leurgans S, Raman R, Stebbins GT. Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 8; 54(3): 710–710. DOI: 10.1212/WNL.54.3.710
    Back to article
  32. 32Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, et al. The placebo effect on resting tremor in Parkinson’s disease: an electrophysiological study. Parkinsonism & Related Disorders. 2018 Jul; 52: 17–23. DOI: 10.1016/j.parkreldis.2018.03.012
    Back to article
  33. 33Malling ASB, Morberg BM, Wermuth L, Gredal O, Bech P, Jensen BR. The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson’s disease. J NeuroEngineering Rehabil. 2019 Dec; 16(1): 19. DOI: 10.1186/s12984-019-0491-2
    Back to article
DOI: https://doi.org/10.5334/tohm.762 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Feb 28, 2023
Accepted on: Jun 14, 2023
Published on: Aug 23, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Neuromodulation,
Non-invasive,
Action Tremor,
Parkinson’s Disease,
Transcutaneous Afferent Patterned Stimulation

© 2023 Salima Brillman, Pravin Khemani, Stuart H. Isaacson, Rajesh Pahwa, Ruta Deshpande, Vivien Zraick, Apoorva Rajagopal, Dhira Khosla, Kathryn H. Rosenbluth, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 13 (2023): Issue 1Next article